Smartwatches may be able to identify people who later go on to develop Parkinson's disease as early as seven years before diagnosis, a new study suggests.
LEO Pharma anuncia la aprobación por parte de la Comisión Europea de Adtralza (tralokinumab), un tratamiento biológico innovador para adultos con dermatitis atópica de moderada a grave pmfarma.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmfarma.es Daily Mail and Mail on Sunday newspapers.